Skip to main content
. 2020 Nov 27;11(1):322–332. doi: 10.1002/2211-5463.13026

Fig. 4.

Fig. 4

Effect of miR‐22 mimics/inhibitor on lipid accumulation in human hepatocytes. (A)/(B) Effect of miR‐22 mimics/inhibitor on Sirt1 protein levels in hepatocytes. (C) Effect of miR‐22 mimics/inhibitor on Sirt1 mRNA levels in hepatocytes. (D) Effect of miR‐22 mimics/inhibitor on TG levels in hepatocytes. (E) Effect of miR‐22 mimics/inhibitor on the lipid content of hepatocytes examined via oil red O staining and microscopy. Scale bars: 50 µm. (F) Effect of miR‐22 mimics/inhibitor on relative cell viability of hepatocytes. Data were presented as mean ± SD for three independent experiments. Student's t‐test was conducted. * P < 0.05.